Clot-busting drugs not recommended for most patients with blood clots

Clot-busting drugs not recommended for most patients with blood clots

About half of people with blood clots in the deep veins of their legs develop a complication that involves chronic limb pain and swelling, making it difficult for some to walk and perform daily activities. A large-scale clinical trial has shown that a risky, costly procedure to remove such clots fails to reduce the likelihood that patients will develop the debilitating complication.
Obesity prevented in mice fed high-fat diet

Obesity prevented in mice fed high-fat diet

Researchers at Washington University School of Medicine in St. Louis have identified a way to prevent fat cells from growing larger, a process that leads to weight gain and obesity. By activating a pathway in fat cells in mice, the researchers found they could feed the animals a high-fat diet without making them obese.
Cutting NIH budget could cripple drug development

Cutting NIH budget could cripple drug development

New research indicates that more than 90 percent of the newest and most widely prescribed drugs on the market needed National Institute of Health (NIH) funding early in their development. The researchers believe proposed cuts to the NIH budget could cripple future development of new, life-saving drugs.
View More Stories